Insulin-oligomer conjugates, formulations and uses thereof

Details for Australian Patent Application No. 2011205115 (hide)

Owner Biocon Limited

Inventors Radhakrishnan, Balasingam; Aggarwal, Diti; Polowy, Karen; Ekwuribe, Nnochirii N.; Pavliv, Leo; Miller, Mark A.; Ferro, Michelle; Malkar, Navdeep B.; James, Kenneth D.

Agent Callinan

Pub. Number AU-A-2011205115

Parent 2005269753

Filing date 2 August 2011

Wipo publication date 18 August 2011

International Classifications

C07K 14/62 (2006.01) Peptides having more than 20 amino acids

A61K 38/18 (2006.01) Medicinal preparations containing peptides - Growth factors

A61K 38/21 (2006.01) Medicinal preparations containing peptides - Interferons

A61K 38/22 (2006.01) Medicinal preparations containing peptides - Hormones

A61K 38/28 (2006.01) Medicinal preparations containing peptides - Insulins

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

Event Publications

18 August 2011 Application Open to Public Inspection

  Published as AU-A-2011205115

18 August 2011 Complete Application Filed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011205116-Preparation of 2,5-(hydroxymethyl)furaldehyde (hmf), derivatives thereof and levulinic acid from fructose as well as preparation of 2,5-bis- (hydroxymethyl) furan from 2,5- (hydroxymethyl) furaldehyde (3)

2011205114-Catheter entanglement indication